Results 101 to 110 of about 7,956 (220)
La maladie de Dupuytren : appareillage, kinésithérapie
Prise en charge kinésithérapique de la maladie de Dupuytren, rétraction de l'aponévrose palmaire superficielle (tissu fibreux situé entre la peau et les tendons fléchisseurs à la paume des mains)
Marcadet, Blandine
core
Havelange Isabelle, Huguet Françoise, Lebedeff-Choppin Bernadette. DUPUYTREN Guillaume, baron. In: Havelange Isabelle, Huguet Françoise, Lebedeff-Choppin Bernadette. Les inspecteurs généraux de l'Instruction publique. Dictionnaire biographique 1802-1914.
Huguet, Françoise +2 more
core
Complications Following Collagenase Treatment for Dupuytren Contracture
Background: Collagenase Clostridium histolyticum (CCH) injection and manipulation is a relatively new method for treating Dupuytren contracture that is growing in popularity.
Clifford Canepa +3 more
core +1 more source
Guillaume Dupuytren. Illustration by Venita Jay, MD, FRCPC. R from grinding poverty and struggles in early life to become France’s leading surgeon and millionaire, Baron Guillaume Dupuytren (1777–1835) remains one of the most enigmatic figures in surgical history.
openaire +2 more sources
Neue molekulare Charakteristika von Zellisolaten aus Dupuytren- Gewebe [PDF]
Zielsetzung und Fragestellung: Goldstandard in der Therapie des fortgeschrittenen Morbus Dupuytren ist nach wie vor die partielle Aponeurektomie mit allen bekannten Nebenwirkungen.
Vaerst, Barbara
core
Dupuytren disease: Prevalence, treatment and outcome [Elektronisk resurs]
Purpose To study the epidemiology of Dupuytren disease and evaluate treatment outcome of collagenase injections using a modified method. Patients and methods Paper I is a register-based study.
Nordenskjöld, Jesper,, Lund University.
core
Dupuytren\u27s disease (DD) is a chronic condition in which fibrosis of tissue beneath the palm of the hand occurs. Causes and mechanisms of this disease\u27s development are still not entirely understood.
Pinckney, Leah C.
core
Epidemiology of Dupuytren disease unraveled:Prevalence, risk factors and disease course [PDF]
Bij de meeste patiënten met de ziekte van Dupuytren verergert hun aandoening over tijd, hoewel er ook mensen zijn bij wie de ziekte stabiel is of zelfs verbetert. Dit is de belangrijkste bevinding uit dit proefschrift.
Broekstra, Dieuwke
core

